Oxford

Chennai: In a setback to the development of COVID-19 vaccines in India, a 40-year-old man has sent a legal notice to Serum Institute of India (SII) and others seeking Rs 5 crore in…

London: British pharma company AstraZeneca said on Saturday it has restarted COVID-19 vaccine trial after getting the go-ahead from the country's regulators. The vaccine trial was paused…

New Delhi: With pharma giant AstraZeneca pausing the Oxford COVID-19 vaccine candidate's trials in other countries, the Serum Institute of India (SII) has been suspended by the Drugs…

London: Two days after the worrying news of the clinical trials of Oxford-AstraZeneca's COVID vaccine candidate being halted, the drugmaker revealed that a participant had developed severe…

London: In a bit of a setback, a phase 3 clinical study of the COVID-19 vaccine developed by the University of Oxford and British pharmaceutical company AstraZeneca has placed a 'routine…

Pune: Serum Institute of India’s (SII) phase 2 trial of Oxford's COVID-19 vaccine candidate is set to commence on Tuesday. The determination of safety and immunogenicity of “Covishield”…

New Delhi: The phase III trials of the Oxford vaccine for COVID-19 are likely to start this week in India. According to a report in India Today TV, the trials are likely to begin as early…

New Delhi: The Drugs Controller General of India (DCGI) has given green signal to Pune-based Serum Institute of India (SII) to conduct the phase 2 and 3 of clinical human trials of the…

New Delhi: Around 160 vaccines currently are being developed for COVID-19, and 25 of these are in human trial phases, according to the World Health Organization (WHO). These include Zydus…

London: The COVID-19 experimental vaccine by AstraZeneca and UK's Oxford University has been found to be safe and has produced an immune response in the early clinical trials. The…